The upfront acquisition of 91.8% of shareholding in Pharmarack is expected to be completed within a period of 30 (thirty) days by purchase of shares from multiple existing shareholders in various lots.
The remaining 8.2% of the shareholding in Pharmarack is likely to be acquired in multiple tranches over the next 5 (five) years.
Cost of acquisition to DigiHealth Technologies LLP for upfront acquisition of 91.8% is Rs 111 crore.
Powered by Capital Market - Live News